We have located links that may give you full text access.
Study of Antichromatin Antibodies As A Marker of Lupus Activity and Lupus Nephritis.
Egyptian Journal of Immunology 2018 January
Systemic Lupus Erythematosus (SLE) is a chronic and potentially fatal autoimmune disorder characterized by the production of auto-antibodies that cause widespread tissue damage. Validate Antichromatin antibodies as a biomarker of renal involvement in SLE and how their titers correlate with systemic lupus activity measure (SLAM) index among a sample of Egyptian systemic lupus patients. The study was conducted on 60 patients diagnosed according to ACR criteria for diagnoses of SLE (Group I) and 25 age matched healthy controls (Group II). Group I was divided into 30 patients without nephritis group A 1 and 30 patients with nephritis group IB. (anti-dsDNA, Antinuclear antibodies ANA), rheumatoid factor (RF), Complement component C3, C4 and antichromatin antibodies were done for all patients and controls. Serum antichromatin antibodies were positive in all cases of SLE and negative in all control subjects and were higher in group1B than group IA also; there were significant positive correlation between antichromatin antibodies and SLAM score of disease activity and classes of nephropathy. In conclusion, measurement of antichromatin antibodies is a useful addition to the laboratory work up for diagnosis and monitoring of SLE and prediction of lupus nephritis.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app